Kamber L Hart1, Roy H Perlis1, Thomas H McCoy2. 1. Center for Quantitative Health, Massachusetts General Hospital, 185 Cambridge Street, 6th Floor, Boston, MA 02114, USA. 2. Center for Quantitative Health, Massachusetts General Hospital, 185 Cambridge Street, 6th Floor, Boston, MA 02114, USA. Electronic address: thmccoy@partners.org.
Abstract
BACKGROUND: Low rates of medication adherence remain a major challenge across psychiatry. In part, this likely reflects patient concerns about safety and adverse effects, accurate or otherwise. We therefore sought to characterize online information about common psychiatric medications in terms of positive and negative sentiment. METHODS: We applied a natural language processing tool to score the sentiment expressed in web search results for 51 psychotropic medications across 3 drug classes (antidepressants, antipsychotics, and mood stabilizers), as a means of seeing if articles referencing these medications were generally positive or generally negative in tone. We compared between medications of the same class, and across medication classes. RESULTS: Across 12,733 web search results, significant within-class differences in positive (antidepressants: F(24,2682) = 2.97, p < 0.001; antipsychotics: F(16,4029) = 3.25, p < 0.001; mood stabilizers: F(8,2371) = 6.88, p < 0.001) and negative sentiment (antidepressants: F(24,6282) = 11.17, p < 0.001; antipsychotics: F(16, 4029) = 12.13, p < 0.001; mood stabilizers: F(8, 2371) = 13.28, p < 0.001) were identified. Among these were significantly greater negative sentiment for the antidepressants sertraline, duloxetine, venlafaxine, and paroxetine, and for the antipsychotics, quetiapine and risperidone. Conversely, lithium preparations and valproate exhibited less negative sentiment than other mood stabilizing medications. LIMITATIONS: While these results provide a novel means of comparing medications, the present analyses cannot be linked to individual patient consumption of this information, or to its influence on their future clinical interactions. CONCLUSIONS: Overall, a subset of psychotropic medications were associated with significantly more negative sentiment. Characterizing these differences may allow clinicians to anticipate patient willingness to initiate or continue medications.
BACKGROUND: Low rates of medication adherence remain a major challenge across psychiatry. In part, this likely reflects patient concerns about safety and adverse effects, accurate or otherwise. We therefore sought to characterize online information about common psychiatric medications in terms of positive and negative sentiment. METHODS: We applied a natural language processing tool to score the sentiment expressed in web search results for 51 psychotropic medications across 3 drug classes (antidepressants, antipsychotics, and mood stabilizers), as a means of seeing if articles referencing these medications were generally positive or generally negative in tone. We compared between medications of the same class, and across medication classes. RESULTS: Across 12,733 web search results, significant within-class differences in positive (antidepressants: F(24,2682) = 2.97, p < 0.001; antipsychotics: F(16,4029) = 3.25, p < 0.001; mood stabilizers: F(8,2371) = 6.88, p < 0.001) and negative sentiment (antidepressants: F(24,6282) = 11.17, p < 0.001; antipsychotics: F(16, 4029) = 12.13, p < 0.001; mood stabilizers: F(8, 2371) = 13.28, p < 0.001) were identified. Among these were significantly greater negative sentiment for the antidepressants sertraline, duloxetine, venlafaxine, and paroxetine, and for the antipsychotics, quetiapine and risperidone. Conversely, lithium preparations and valproate exhibited less negative sentiment than other mood stabilizing medications. LIMITATIONS: While these results provide a novel means of comparing medications, the present analyses cannot be linked to individual patient consumption of this information, or to its influence on their future clinical interactions. CONCLUSIONS: Overall, a subset of psychotropic medications were associated with significantly more negative sentiment. Characterizing these differences may allow clinicians to anticipate patient willingness to initiate or continue medications.
Authors: Joseph Zohar; Stephen Stahl; Hans-Jurgen Moller; Pierre Blier; David Kupfer; Shigeto Yamawaki; Hiroyuki Uchida; Michael Spedding; Guy M Goodwin; David Nutt Journal: Eur Neuropsychopharmacol Date: 2015-09-07 Impact factor: 4.600
Authors: Thomas H McCoy; Victor M Castro; Hannah R Rosenfield; Andrew Cagan; Isaac S Kohane; Roy H Perlis Journal: Am J Psychiatry Date: 2015-04 Impact factor: 18.112
Authors: Kenneth Portier; Greta E Greer; Lior Rokach; Nir Ofek; Yafei Wang; Prakhar Biyani; Mo Yu; Siddhartha Banerjee; Kang Zhao; Prasenjit Mitra; John Yen Journal: J Natl Cancer Inst Monogr Date: 2013-12
Authors: T Scott Stroup; Jeffrey A Lieberman; Joseph P McEvoy; Marvin S Swartz; Sonia M Davis; Robert A Rosenheck; Diana O Perkins; Richard S E Keefe; Clarence E Davis; Joanne Severe; John K Hsiao Journal: Am J Psychiatry Date: 2006-04 Impact factor: 19.242
Authors: Thomas H McCoy; Victor M Castro; Andrew Cagan; Ashlee M Roberson; Isaac S Kohane; Roy H Perlis Journal: PLoS One Date: 2015-08-24 Impact factor: 3.240
Authors: Victor M Castro; Thomas H McCoy; Andrew Cagan; Hannah R Rosenfield; Shawn N Murphy; Susanne E Churchill; Isaac S Kohane; Roy H Perlis Journal: BMJ Date: 2014-10-24
Authors: Kamber L Hart; Amelia M Pellegrini; Brent P Forester; Sabina Berretta; Shawn N Murphy; Roy H Perlis; Thomas H McCoy Journal: Gen Hosp Psychiatry Date: 2020-11-10 Impact factor: 3.238
Authors: Christophe Lemey; Aziliz Le Glaz; Yannis Haralambous; Deok-Hee Kim-Dufor; Philippe Lenca; Romain Billot; Taylor C Ryan; Jonathan Marsh; Jordan DeVylder; Michel Walter; Sofian Berrouiguet Journal: J Med Internet Res Date: 2021-05-04 Impact factor: 5.428